CERS Quote, Trading Chart, Cerus Corporation
home / stock / cers / cers quote
$6.14 Last:
-4.81% Change Percent:
$6.2621 Open:
$6.14 Previous Close:
$6.69 High:
$5.9 Low:
3,568,536 Volume:
02/26/2021 04:55:25 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-26 | 6.2621 | 6.14 | 6.69 | 5.9 | 3,568,536 |
| 2021-02-25 | 6.7 | 6.45 | 6.829 | 6.1 | 3,715,198 |
| 2021-02-24 | 6.71 | 6.72 | 6.93 | 6.5 | 1,615,893 |
| 2021-02-23 | 7.04 | 6.77 | 7.04 | 6.37 | 3,388,081 |
| 2021-02-22 | 7.36 | 7.24 | 7.46 | 7.1 | 1,836,009 |
| 2021-02-19 | 7.31 | 7.49 | 7.64 | 7.31 | 1,485,579 |
| 2021-02-18 | 7.4 | 7.3 | 7.55 | 7.02 | 1,699,090 |
| 2021-02-17 | 7.62 | 7.55 | 7.88 | 7.37 | 1,454,443 |
| 2021-02-16 | 7.7834 | 7.75 | 7.95 | 7.615 | 1,932,376 |
| 2021-02-15 | 7.42 | 7.55 | 7.62 | 7.26 | 1,083,197 |
| 2021-02-12 | 7.42 | 7.55 | 7.62 | 7.26 | 1,082,741 |
| 2021-02-11 | 7.85 | 7.5 | 7.88 | 7.41 | 1,135,146 |
| 2021-02-10 | 7.98 | 7.68 | 8.39 | 7.64 | 1,778,581 |
| 2021-02-09 | 7.91 | 7.85 | 8.21 | 7.83 | 1,660,318 |
| 2021-02-08 | 7.65 | 7.87 | 8.41 | 7.64 | 3,043,074 |
| 2021-02-05 | 7.64 | 7.54 | 7.72 | 7.345 | 1,542,028 |
| 2021-02-04 | 7.32 | 7.5 | 7.62 | 7.22 | 1,610,438 |
| 2021-02-03 | 7.38 | 7.25 | 7.58 | 7.245 | 1,744,374 |
| 2021-02-02 | 6.96 | 7.29 | 7.45 | 6.91 | 2,613,756 |
| 2021-02-01 | 6.66 | 6.76 | 6.81 | 6.54 | 1,734,360 |
News, Short Squeeze, Breakout and More Instantly...
-
Image source: The Motley Fool. Cerus Corporation (NASDAQ: CERS) Q4 2020 Earnings Call Feb 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cerus Corporation (CERS) Q4 2020 Earnings Call Transcript
-
Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and year ended December 31, 2020. Recent developments and highlights include: Record total fourth quarter and full year 2020 revenues of $33.6 million and $114.2 million, respectively. ...
-
Joint Venture Will Enable Cerus to Partner with Leader in Transfusion Medicine to Bring INTERCEPT to the Mainland China Transfusion Market Cerus Corporation (Nasdaq: CERS) and Shandong Zhongbaokang Medical Implements Co. Ltd. (ZBK) today announced that they are forming a joi...